Concepedia

Author

Susanne Hartz

Eli Lilly (United Kingdom)ORCID

Also Known As

Hartz, Susanne, S Hartz, S. Hartz, S.C. Hartz, Susanne C Hartz, Susanne Hartz

44

Publications

670

Citations

11

H-Index

15

Concepts

All Affiliations

Eli Lilly (United Kingdom)Eli Lilly (Germany)Eli Lilly (United States)
SH

About

Susanne Hartz is an author at Eli Lilly (United Kingdom) specializing in medicine, dermatology, and psoriatic arthritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

113

2

Public Health

1

1

99

3

Obstetrics

1

1

99

4

Reproductive Health

1

1

99

5

Developmental Biology

1

1

99

Susanne Hartz

×

8

Publications

464

Citations

8

H-Index

YearCitations

Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study

Kristian Reich, Andreas Pinter, J.‐P. Lacour,

British Journal of Dermatology

2017

185

In vitro fertilization‐embryo transfer (ivf‐et) in the united states: 1990 results from the ivf‐et registry

Susanne Hartz

International Journal of Gynecology & Obstetrics

1992

99

Clearing up the hazy road from bench to bedside: A framework for integrating the fourth hurdle into translational medicine

Wolf Rogowski, Susanne Hartz, Jürgen John

BMC Health Services Research

2008

48

Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation

Susanne Hartz, Denis Getsios, Sunning Tao,

BMC Neurology

2012

39

EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis

A. Simon Pickard, Melinda Gooderham, Susanne Hartz,

Journal of Medical Economics

2016

30

Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis

S. Al Sawah, Shonda A. Foster, Russel Burge,

Journal of Medical Economics

2017

28

Network meta‐analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method

Ulrich Mrowietz, Richard B. Warren, C. Leonardi,

Journal of the European Academy of Dermatology and Venereology

2021

21

Network Meta-Analysis To Evaluate The Efficacy of Ixekizumab In The Treatment of Moderate-To-Severe Psoriasis

Susanne Hartz, Stefan Walzer, Yves Dutronc,

Value in Health

2016

14

Page 1